{
    "nct_id": "NCT06534424",
    "official_title": "The caRe Study: Clinical Application of Refined Risk Estimates",
    "inclusion_criteria": "* Have had genetic counseling and testing for mutations in BRCA1 and/or BRCA2 through a Clinical Laboratory Improvement Act (CLIA)-certified laboratory\n* Were found to have a known pathogenic mutation upon testing\n* Are within 3 weeks of results disclosure\n* Have available medical records for ascertainment of clinical information\n* Are able to provide a source of deoxyribonucleic acid (DNA) (blood or mouthwash) for study\n* Have access to a telephone and a computer or other internet-ready device\n* Have not yet had a bilateral prophylactic mastectomy or bilateral Salpingo oophorectomy\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}